COS cell expression studies of P86L, P86R, P480L and P480Q Hunter's disease-causing mutations

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1406, Issue 2, 1998, Pages 214-218

  Millat, Gilles ^a   Froissart, Roseline ^a   Cudry, Stéphane ^a   Bonnet, Véronique ^a   Maire, Irène ^a   Bozon, Dominique ^a  

^a HÔPITAL DEBROUSSE   (France)

Author keywords

Expression study; Hunter's disease; Iduronate 2 sulfatase (IDS); Lysosome; Mucopolysaccharidosis

Indexed keywords

IDURONATE 2 SULFATASE;

ADOLESCENT; AGED; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; HUNTER SYNDROME; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING;

ADOLESCENT; ANIMALS; COS CELLS; DNA, COMPLEMENTARY; HUMANS; IDURONATE SULFATASE; MIDDLE AGED; MUCOPOLYSACCHARIDOSIS II; MUTATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS;

ANIMALIA;

EID: 0032485490     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(97)00096-3     Document Type: Article

References (20)

1. [1] E.F. Neufeld, J. Muenzer, The mucopolysaccharidoses, in: C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.), The Metabolic Basis of Inherited Disease, 6th edn., McGraw-Hill, New York, 1989, pp. 1565-1587.
2. [2] J. Bielecki, C. Freeman, P.R. Clements, J.J. Hopwood, Human liver iduronate-2-sulphatase: Purification, characterization and catalytic properties, Biochem. J. 271 (1990) 75-86.
3. [3] P.J. Wilson, C.P. Morris, D.S. Anson, T. Occhiodoro, J. Bielicki, P.R. Clements, J.J. Hopwood, Hunter syndrome: Isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA, Proc. Natl. Acad. Sci. U.S.A. 87 (1990) 8531-8535.
4. [4] R.H. Flomen, E.P. Green, P.M. Green, D.R. Bentley, F. Giannelli, Determination of the organisation of coding sequences within the iduronate sulphate sulphatase (IDS) gene, Hum. Mol. Genet. 2 (1993) 5-10.
5. [5] P.J. Wilson, C.A. Meaney, J.J. Hopwood, C.P. Morris, Sequence of the human iduronate 2-sulfatase (IDS) gene, Genomics 17 (1993) 773-775.
6. [6] R. Froissart, G. Millat, M. Mathieu, D. Bozon, I. Maire, Processing of iduronate-2-sulphatase in human fibroblasts, Biochem. J. 309 (1995) 425-430.
7. [7] G. Millat, R. Froissart, I. Maire, D. Bozon, IDS transfer from overexpressing cells to IDS-deficient cells, Exp. Cell Res. 230 (1997) 362-367.
8. [8] E. Popowska, M. Rathmann, A. Tylki-Szymanska, S. Bunge, C. Steglich, E. Schwinger, A. Gal, Mutations of iduronate-2-sulfatase gene in 12 Polish patients with mucopolysaccharidosis type II (Hunter syndrome), Hum. Mutat. 5 (1995) 97-100.
9. [9] S. Bunge, C. Steglich, C. Zuther, M. Beck, C.P. Morris, E. Schwinger, A. Schinzel, J.J. Hopwood, A. Gal, Iduronate-2-sulfatase gene mutations in 16 patients with mucopolysaccharidosis type II (Hunter syndrome), Hum. Mol. Genet. 2 (1993) 1871-1875.
10. [10] S.L. Goldenfum, E. Young, H. Michelakakis, S. Tsagarakis, B. Winchester, Mutation analysis in 20 patients with Hunter disease, Hum. Mutat. 7 (1996) 76-78.
11. [11] J.M. Chirgwin, A.E. Przbyla, R.J. MacDonald, W.J. Rutter, Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry 18 (1979) 5294-5299.
12. [12] M. Jeanpierre, A rapid method for the purification of DNA from blood, Nucleic Acids Res. 15 (1987) 9611.
13. [13] K. Sukegawa, S. Tomatsu, T. Fukao, H. Iwata, X.Q. Song, Y. Yamada, S. Fukuda, K. Isogai, T. Orii, Mucopolysaccharidosis type II (Hunter disease): Identification and characterization of eight point mutations in the iduronate sulfatase gene in Japanese patients, Hum. Mutat. 6 (1995) 136-143.
14. [14] B. Franco, G. Meroni, G. Parenti, J. Levilliers, L. Bernard, M. Gebbia, L. Cox, P. Marotaux, L. Sheffield, G.A. Rappold, G. Andria, C. Petit, A. Ballabio, A cluster of sulfatases genes on Xp22.3: Mutations in chondrodysplasia punctata (CDPX) and implications for warfarin embryopathy, Cell 81 (1995) 15-25.
15. [15] B. Schmidt, T. Selmer, A. Ingendoh, K. von Figura, A novel amino acid modification in sulfatases that is defective in multiple sulfatase deficiency, Cell 82 (1995) 271-278.
16. [16] C.S. Bond, P.R. Clements, S.J. Ashby, C.A. Collyer, S.J. Harrop, J.J. Hopwood, Structure of a human lysosomal sulfatase, Structure 5 (1997) 277-289.
17. [17] W. Rommerskirch, K. von Figura, Multiple sulfatase deficiency: Catalytically inactive sulfatases are expressed from retrovirally introduced sulfatase cDNAs, Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 2561-2565.
18. [18] G. Millat, R. Froissart, I. Maire, D. Bozon, Characterization of IDS mutants affecting N-glycosylation sites and the 84 cysteine residue, Biochem. J. 326 (1997) 243-247.
19. [19] D.A. Brooks, D.A. Roberstson, C. Bindloss, T. Litjens, D.S. Anson, C. Peters, C.P. Morris, J.J. Hopwood, Two site-directed mutations abrogate enzyme activity but have different effects on the conformation and cellular content of the N-acetylgalactosamine 4-sulphatase protein, Biochem. J. 307 (1996) 457-463.
20. [20] G.H. Thomas, Pseudodeficiencies of lysosomal hydrolases, Am. J. Hum. Genet. 54 (1994) 934-940.